Skip to content

Epidemiology and Household Transmission of Streptococcus Pneumoniae and Respiratory Syncytial Virus

Epidemiology and Transmission of Streptococcus Pneumoniae and Respiratory Syncytial Virus in Children and Elderly: a Household-based Prospective Cohort Study

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05017519
Enrollment
240
Registered
2021-08-24
Start date
2021-10-01
Completion date
2026-07-31
Last updated
2021-08-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory Syncytial Virus Infections, Streptococcus Pneumoniae Infection

Keywords

Streptococcus Pneumoniae, Respiratory Syncytial Virus, household-based

Brief summary

This household-based prospective cohort study aims to stablish the household transmission of Respiratory syncytial virus and S. pneumoniae especially in the elderly and infants/children as well as inter-relationship between S. pneumoniae and Respiratory syncytial virus.

Detailed description

A household-based prospective cohort study will be conducted from 2021 to 2025 in northern Taiwan. We will invite 240 households, having a baby who is discharged from MacKay children's Hospital. The households will be classified into nuclear family type and extended family type. The Nuclear family type is defined as husband and wife with baby (aged less than 5 months) and with or without children (2-5) and the Extended family type (three-generation family) is defined as husband and wife with baby (aged less than 5 months), children (2-5), and grandparents aged \> 65 years old. We will initially complete an enrollment form to collect baseline data, including patient demographics, prior medical history, season when discharge, neonatal course and households. A LINE-based management will be done weekly by study team to see if there are any respiratory symptoms in household. In addition to the monthly physician weekly LINE response, the research nurse will contact the parents or legal guardians by telephone monthly for the 24 months to obtain data on changes in baseline information, and specific facts regarding possible respiratory infections after the last contact. If the households present with respiratory symptoms, the visit will be arranged as early as possible. When they presenting to the emergency department, outpatient clinic, or inpatient ward, the urine will be collected for the serotype-specific urinary antigen detection (SSUAD) assays and the nasopharyngeal or throat swab for polymerase chain reaction will be performed to study serotype of S. pneumoniae and Respiratory syncytial virus subgroup. If the subjects who have clinical syndromes suggestive of pneumonia or bronchopneumonia, they will be asked to participate in the further study along with their household family members. Nasopharyngeal aspiration, urine, blood, and induced sputum will be collected for cultures, polymerase chain reaction and serological test. Clinical manifestations, disease course, and outcomes will be recorded. Family members in the same household will asked to undergo screening with a nasopharyngeal or throat swab and urine sample. We will trace back 2-week contact history of children in nuclear family who get Respiratory syncytial virus or pneumococcal infections, especially focus on other family members. The data will be further analyzed to evaluate the influence of short period and long period contact.

Interventions

None listed

Sponsors

Merck Sharp & Dohme LLC
CollaboratorINDUSTRY
Mackay Memorial Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Indicator case: Babies under 5 months of age were born in Mackay Children's Hospital and had no acute respiratory infection-like symptoms that required medical intervention when they agreed to participate in the trial. * Family members: family members living with the Indicator case, including 2-5 years old siblings, parents and grandparents over 65 years old. * Willing to sign the informed consent form and agree to join the official LINE account to receive research tracking.

Exclusion criteria

* Babies older than 5 months * Co-morbid medical conditions of the baby such as chronic lung disease, cyanotic congenital heart disease, neuromuscular disease and a primary immunodeficiency. * Family members who do not live with the Indicator case * Family with grandparents younger than 65 years old * Someone living with family members refuses to participate in the research. * Unwilling to sign informed consent form or refuse to join the official LINE account to receive tracking.

Design outcomes

Primary

MeasureTime frameDescription
Household transmission of Streptococcus pneumoniae and Respiratory syncytial virus2 yearsThe primary endpoint is the Streptococcus pneumoniae and Respiratory syncytial virus isolation rates in children and their household contacts of different family type.
The serotype of Streptococcus pneumoniae and Respiratory syncytial virus in post-Prevenar 13 era2 yearsThe secondary endpoint is the serotype of Streptococcus pneumoniae and Respiratory syncytial virus in post-Prevenar 13 era.

Contacts

Primary ContactHsin Chi, Doctor
chi4531@gmail.com+886 975835388
Backup ContactNan-Chang Chiu, Doctor
ncc88@mmh.org.tw+886 975835382

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026